Patent Application
20230183648
The present invention relates to a composition for regulating stem cell function, which comprises the genus Lactobacillus bacteria-derived extracellular vesicles (EVs) as an active ingredient, and a method of regulating stem cell function using the same.
This application claims priority to and the benefit of Korean Patent Application No. 10-2020-0027386, filed on Mar. 4, 2020, and all the contents disclosed in the specification and drawings of the applications are incorporated in this application.
Recently, from archaea, bacteria, viruses to eukaryotes such as yeast and mold, microorganisms maintain a symbiotic relationship with humans by acquiring various ecological niches inside and outside the human body. The number of microorganisms in the human body is more than 10 times the total number of human cells, and the number of genes possessed by microorganisms is also several hundred times the human genome. It is known that these microorganisms perform major functions through interactions with the human body, such as the absorption and metabolism of nutrients in the human body, the maturation and development of the immune system and the nervous system, and influencing the occurrence and prevention of various diseases. As such, a human is a super-organism which has a mixture of cellular and genetic characteristics of numerous symbiotic microorganisms, in addition to human cells and genome, and the collection of all microorganisms that are naturally present in the human body is called a microbiome.
The human microbiome is dynamically changed due to various factors such as an individual, family, race, gender, age, diet, region, and lifestyle. However, it was found that, unlike the diversity of microbial species constituting each individual's microbial community, the core functional genes constituting the microbiome are common for the most part despite the difference in individual characteristics and environmental conditions.
Therefore, human-derived adult stem cells may also undergo changes in stemness, which is the unique characteristic of stem cells, according to the action of the microbiome. Various stem cell studies using adult stem cells are being actively conducted, and for the development of cell therapeutics using adult stem cells, it is necessary to identify a microbiome that affects stem cells. In fact, multi-modal studies on the extracellular vesicles (EVs), which are substances secreted from various microbiomes for general cells, are ongoing, but there is no such thing as a clear indicator substance.
The present invention is provided to solve the above-described problems in the related art, and the present invention is directed to providing a composition for regulating stem cell function, comprising the genus Lactobacillus bacteria-derived extracellular vesicles (EVs) as an active ingredient.
The present invention is also directed to providing a method of regulating stem cell function, comprising treating a stem cell culture medium with the genus Lactobacillus bacteria-derived extracellular vesicles (EVs).
However, a technical problem to be achieved by the present invention is not limited to the aforementioned problems, and the other problems that are not mentioned may be clearly understood by a person skilled in the art from the following description.
To achieve the purpose of the present invention, the present invention provides a composition for regulating stem cell function, comprising the genus Lactobacillus bacteria-derived extracellular vesicles (EVs) as an active ingredient.
In one embodiment of the present invention, the genus Lactobacillus bacteria may comprise, for example, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, and the like, but there is no limitation on the species.
In another embodiment of the present invention, the genus Lactobacillus bacteria may be derived from the human body, but the present invention is not limited thereto.
In one embodiment of the present invention, the stem cell may be a mesenchymal stem cell, but the present invention is not limited thereto.
In another embodiment of the present invention, the stem cell may be a tonsil-derived stem cell, but the present invention is not limited thereto.
In still another embodiment of the present invention, the composition may promote the proliferation of a stem cell.
In yet another embodiment of the present invention, the concentration of extracellular vesicles (EVs) may be 10 to 1000 μg/ml, but the present invention is not limited thereto.
In yet another embodiment of the present invention, the EVs may have an average diameter of 10 to 200 nm, but the present invention is not limited thereto.
In yet another embodiment of the present invention, the EVs may have a zeta potential of −60 to 30 mV, but the present invention is not limited thereto.
In yet another embodiment of the present invention, the EVs may be naturally or artificially secreted from the genus Lactobacillus bacteria.
In addition, the present invention provides a method of regulating stem cell function, comprising treating a stem cell culture medium with the genus Lactobacillus bacteria-derived extracellular vesicles.
In one embodiment of the present invention, the culture medium may be selected from the group consisting of DMEM medium, DMEM/F12 medium, M199/F12 mixture, MEM-α medium, MCDB 131 medium, IMEM medium, PCM medium, and MSC expansion medium, but the present invention is not limited thereto.
In another embodiment of the present invention, the method may be to regulate the proliferation rate of stem cells.
The present invention relates to a composition for regulating stem cell function, comprising the genus Lactobacillus bacteria-derived extracellular vesicles (EVs) as an active ingredient, and a method of regulating stem cell function, comprising treating a stem cell culture medium with the genus Lactobacillus bacteria-derived extracellular vesicles (EVs). By using the composition or method according to the present invention, there is an effect of greatly improving the proliferative potential of a stem cell. In addition, the EVs are naturally secreted from a symbiotic the genus Lactobacillus strain in human tonsillar tissue and may be a human-friendly and natural substance compared to the promotion of stem cell proliferation by the treatment with a chemical drug. Therefore, aged stem cells, which have lost their value as stem cells, can have enhanced proliferation with minimal toxicity and side effects and are expected to be used in various research fields.
As a result of making an effort to find microbiome extracellular vesicles affecting stem cells, the inventors confirmed that the genus Lactobacillus bacteria-derived extracellular vesicles affect the proliferation potential and stemness of human tonsillar tissue-derived stem cells, and the present invention was completed.
Thus, the present invention may provide a composition for regulating stem cell function, comprising the genus Lactobacillus bacteria-derived extracellular vesicles (EVs) as an active ingredient.
As used herein, the term “extracellular vesicle” refers to a structure formed of a nano-sized membrane secreted from various bacteria. Vesicles derived from gram-positive bacteria such as Lactobacillus include peptidoglycan and lipoteichoic acid, which are components of the bacterial cell wall, and various low-molecular compounds in the vesicle, as well as proteins and nucleic acids.
There is no limitation on the genus Lactobacillus bacterial species. For example, L. paracasei, L. plantarum, L. rhamnosus, L. acidophilus, L. amylovorus, L. casei, L. brevis, L. crispatus, L. delbrueckii subsp. lactis, L. bulgaricus, L. fermentum, L. helveticus, L. gallinarum, L. gasseri, L. johnsonii, L. reuteri, L. salivarius, L. alimentarius, L. curvatus, L. casei subsp. casei, and L sake may be included in the scope of the present invention.
The genus Lactobacillus bacteria of the present invention may be derived from the human body, and preferably may be, a Lactobacillus strain derived from the same tissue as tissue from which stem cells are derived. For example, to control human tonsillar tissue-derived mesenchymal stem cell function, a symbiotic Lactobacillus strain in the human tonsil may be isolated, and extracellular vesicles secreted therefrom may be isolated, or extracellular vesicles artificially isolated by culturing the isolated Lactobacillus strain may be used. However, the origin of Lactobacillus bacteria is not limited to being derived from specific tissue, but the present invention is not limited thereto.
The genus Lactobacillus bacteria-derived EVs of the present invention may be naturally or artificially secreted, or may be isolated from the culture of the genus Lactobacillus bacteria or food fermented with the genus Lactobacillus bacteria. A method of isolating EVs from the cell culture or the bacteria-added fermented food may be isolating EVs from the culture or fermented food which includes EVs using centrifugation, ultra-high-speed centrifugation, filtration through a filter, gel filtration chromatography, free-flow electrophoresis, capillary electrophoresis, and a combination thereof, but the present invention is not limited thereto. In addition, processes such as removing impurities and concentration of the acquired EVs may be further included.
The EVs isolated by the above method may have an average diameter of 10 to 200 nm, and preferably 50 to 150 nm, but the present invention is not limited thereto. In addition, the EV particles may have a zeta potential of −60 to 30 mV, and since most particles have a zeta potential of −30 to −20 mV, they may be stably dispersed in a stem cell medium such as DMEM.
The term “function regulation” used herein refers to an action affecting the functions of all stem cells, including the proliferative potential of stem cells, by treating the stem cells with the composition according to the present invention. Particularly, the composition according to the present invention may have an effect of dramatically improving the proliferative potential of stem cells, and it was shown that the proliferative potential is improved even when stem cells lose sternness due to aging (see Example 3). Therefore, the “function” used herein preferably refers to the proliferative potential of stem cells, and the “regulation” preferably refers to control of the proliferation rate of stem cells, but the present invention is not limited thereto.
The term “proliferation” used herein refers to an increase in cell count. According to an exemplary embodiment of the present invention, it was confirmed that, when the same amount of stem cells are treated with the genus Lactobacillus bacteria-derived EVs, growth and proliferation rates are promoted.
The term “stem cell” used herein refers to a cell with pluripotency which allows the cell to differentiate into endoderm, mesoderm and ectoderm-derived animal cells and limited differentiation potential (multipotency) which allows the cell to differentiate into closely related cells. The stem cells that can be used for the purpose of the present invention may be included without limitation.
The type of stem cell to which a composition for regulating stem cell function according to the present invention can be applied is not limited, but in one embodiment of the present invention, the stem cells may be mesenchymal stem cells derived from the tonsils, bone marrow, umbilical cord blood or adipose tissue. The mesenchymal stem cells may be isolated from mammals, such as a human, a mouse, a rat, a guinea pig, a rabbit, a monkey, a pig, a horse, a cow, a sheep, an antelope, a dog or a cat, but the present invention is not limited thereto. The mesenchymal stem cells are preferably isolated from a human. A method of acquiring such mesenchymal stem cells is well known in the art.
As another aspect of the present invention, the present invention may provide a method of regulating stem cell function, comprising treating a stem cell culture medium with the genus Lactobacillus bacteria-derived extracellular vesicles.
The stem cell culture medium is a known basic medium commonly used for cell culture, which may be, for example, Dulbecco's modified Eagle's medium (DMEM), Dulbecco's modified Eagle's medium/Ham's F-12 (DMEM/F12), an M199/F12 mixture, alpha minimal essential medium (MEM-α), MCDB 131 medium, IMEM medium, PCM medium, or MSC expansion medium, but the present invention is not limited thereto.
These basic media contain a salt, a vitamin, a buffer, an energy source, an amino acid, and other substances, and when culturing stem cells, contain approximately 10 to 30% of animal-derived serum to provide universal nutrients for the growth of cells to be cultured.
The serum used in the culture of stem cells may be fetal, calf, horse or human serum, and preferably, fetal bovine serum (FBS). In addition, a compound having a component similar to that of animal-derived serum, for example, a bovine pituitary extract (BPE), may be used.
In addition, when culturing stem cells, it is preferable to add an antibiotic, an antifungal agent, and a reagent for preventing the growth of mycoplasma causing contamination. As an antibiotic, one that is used in common cell culture, such as penicillin, streptomycin or fungizone may be used. It is preferable to use amphotericin B as an antifungal agent and tylosin as a mycoplasma inhibitor, and gentamicin, ciprofloxacin, or azithromycin may be used to prevent mycoplasma contamination.
An oxidative nutrient such as L-glutamine and an energy metabolite such as sodium pyruvate may be further added as necessary.
The proliferation rat of stem cells may be regulated by treating the medium for stem cell culture with the genus Lactobacillus bacteria-derived EVs according to the present invention at a suitable concentration.
Terms and words used in the specification and claims should not be construed as being limited to general or dictionary terms meanings, and should be interpreted with the meaning and concept in accordance with the technical idea of the present invention based on the principle that the inventors have appropriately defined the concepts of terms in order to explain the invention in the best way.
Hereinafter, preferred Examples for helping the understanding of the present invention will be suggested. However, the following Examples are provided only to more easily understand the present invention, and the contents of the present invention are not limited by the following Examples.
A Lactobacillus paracasei strain expected to have efficacy on tonsillar tissue-derived stem cells was screened by examining a microbiome in tonsillar tissue in the human oral cavity.
To analyze the characteristics of the genus Lactobacillus bacteria-derived EVs isolated in Example 1, the size and morphology of EV particles were observed using transmission electron microscopy, the zeta potential of EVs was measured in a medium for stem cell culture, Eagle's minimal essential medium (DMEM), to analyze repulsion or attraction between particles.
As a result, as shown in
After stem cells were treated with the genus Lactobacillus bacteria-derived EVs isolated in Example 1 at a concentration of 100, 200, 300, 400 and 500 μg/ml, the degrees of stem cell proliferation were confirmed for the same time period.
As a result, as shown in
In addition, after stem cells with significantly reduced proliferative potential due to aging were treated with 100, 200, 300, 400 and 500 μg/ml of the genus Lactobacillus bacteria-derived EVs, cell proliferation saturation was measured for 42 hours at 3-hour intervals.
As a result, as shown in
From the above results, to rapidly proliferate stem cells from the beginning, the stem cells may be treated with 400 to 500 μg/ml of the genus Lactobacillus bacteria-derived EVs, and even when the stem cells were treated with 100 μg/ml of the genus Lactobacillus bacteria-derived EVs, after approximately a day, it was able to be seen that the proliferation of stem cells was promoted to the same level as the case of treatment with a concentration of 500 μg/ml.
Particularly, even when stem cells losing sternness and showing below average growth rates due to aging were treated with the genus Lactobacillus bacteria-derived EVs, it was confirmed that proliferation was significantly improved.
The above-described description of the present invention is provided for illustrative purposes, and those of ordinary skill in the art to which the present invention pertains will understand that the present invention can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. Therefore, it should be understood that the above-described Examples are illustrative only in all aspects and are not restrictive.
The present invention relates to a composition for regulating stem cell function, comprising the genus Lactobacillus bacteria-derived EVs as an active ingredient, and the proliferative potential of stem cells may be greatly improved using the composition according to the present invention. In addition, the EVs are naturally secreted from a symbiotic the genus Lactobacillus strain in human tonsillar tissue, and since the EVs are human-friendly natural substances, compared to the promotion of stem cell proliferation by treatment with a chemical drug, they are considered to have high industrial usefulness as the proliferation of aged stem cells that have lost their value as stem cells is promoted with minimal toxicity and side effects and thus the EVs can be used in various research fields.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2020-0027386 | Mar 2020 | KR | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/KR2021/002511 | 2/26/2021 | WO |
